Publication Listing for the MeSH term giant-cell tumor. Found 2 abstracts

Blay JY, von Mehren M. Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor. Seminars in Oncology. 2011 Apr;38(2):S3-S9.   PMCID: not NIH funded

de Camargo VP, van de Rijn M, de Alava E, Madoz-Gurpide J, Pilotti S, von Mehren M, Pedeutour F, Maki RG, Rutkowski P, Thomas DM. Other Targetable Sarcomas. Seminars in Oncology. 2009 Aug;36(4):358-71.   PMCID: not NIH funded

The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

giant-cell tumor gastrointestinal stromal tumors myeloid-leukemia differential chronic myelogenous leukemia bcr-abl imatinib-resistant amn107 nilotinib mutation c-kit spectrometry-based proteomics chronic sensitivity soft part dermatofibrosarcoma protuberans growth-factor receptor monoclonal-antibody in-vitro activity sarcoma kaposis-sarcoma phase-ii